Capstone Investment Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $322K | Sell |
4,024
-3,294
| -45% | -$272K | ﹤0.01% | 1343 |
|
|
2025
Q4 | $624K | Sell |
7,318
-6,314
| -46% | -$518K | ﹤0.01% | 1062 |
|
|
2025
Q3 | $1.06M | Sell |
13,632
-7,068
| -34% | -$552K | ﹤0.01% | 992 |
|
|
2025
Q2 | $1.62M | Buy |
20,700
+8,723
| +73% | +$651K | ﹤0.01% | 712 |
|
|
2025
Q1 | $868K | Sell |
11,977
-8,217
| -41% | -$588K | ﹤0.01% | 925 |
|
|
2024
Q4 | $1.49M | Sell |
20,194
-4,595
| -19% | -$322K | ﹤0.01% | 934 |
|
|
2024
Q3 | $1.64M | Buy |
24,789
+21,818
| +734% | +$1.59M | 0.01% | 806 |
|
|
2024
Q2 | $274K | Sell |
2,971
-1,696
| -36% | -$150K | ﹤0.01% | 1620 |
|
|
2024
Q1 | $446K | Buy |
+4,667
| New | +$392K | ﹤0.01% | 1625 |
|
|
2023
Q4 | – | Sell |
-15,743
| Closed | -$1.1M | – | 2193 |
|
|
2023
Q3 | $1.09M | Buy |
15,743
+15,593
| +10,395% | +$1.25M | ﹤0.01% | 950 |
|
|
2023
Q2 | $14.2K | Buy |
150
+141
| +1,567% | +$12.3K | ﹤0.01% | 1813 |
|
|
2023
Q1 | $745 | Sell |
9
-9,179
| -100% | -$722K | ﹤0.01% | 1513 |
|
|
2022
Q4 | $686K | Sell |
9,188
-41,513
| -82% | -$3.2M | 0.01% | 1038 |
|
|
2022
Q3 | $4.19M | Buy |
50,701
+31,568
| +165% | +$3.04M | 0.03% | 457 |
|
|
2022
Q2 | $1.82M | Buy |
+19,133
| New | +$1.98M | 0.01% | 805 |
|
|
2021
Q3 | – | Sell |
-1,416
| Closed | -$162K | – | 2018 |
|
|
2021
Q2 | $147K | Sell |
1,416
-10,779
| -88% | -$1.02M | ﹤0.01% | 1531 |
|
|
2021
Q1 | $1.02M | Buy |
+12,195
| New | +$1.03M | ﹤0.01% | 1107 |
|
|
2020
Q3 | – | Sell |
-35,287
| Closed | -$2.75M | – | 1402 |
|
|
2020
Q2 | $2.44M | Buy |
35,287
+3,292
| +10% | +$234K | 0.02% | 646 |
|
|
2020
Q1 | $2.01M | Sell |
31,995
-996
| -3% | -$71.8K | 0.03% | 520 |
|
|
2019
Q4 | $2.56M | Buy |
32,991
+32,964
| +122,089% | +$2.57M | 0.01% | 760 |
|
|
2019
Q3 | $2K | Sell |
27
-126
| -82% | -$8.85K | ﹤0.01% | 1335 |
|
|
2019
Q2 | $9K | Buy |
153
+6
| +4% | +$363 | ﹤0.01% | 1370 |
|
|
2019
Q1 | $9K | Sell |
147
-267
| -64% | -$15.2K | ﹤0.01% | 1262 |
|
|
2018
Q4 | $21K | Buy |
414
+156
| +60% | +$7.89K | ﹤0.01% | 1222 |
|
|
2018
Q3 | $15K | Buy |
+258
| New | +$12.6K | ﹤0.01% | 1253 |
|
|
2017
Q4 | – | Sell |
-45,591
| Closed | -$1.66M | – | 535 |
|
|
2017
Q3 | $1.66M | Buy |
45,591
+5,406
| +13% | +$206K | 0.06% | 168 |
|
|
2017
Q2 | $1.58M | Buy |
40,185
+29,619
| +280% | +$1.08M | 0.04% | 275 |
|
|
2017
Q1 | $331K | Buy |
+10,566
| New | +$331K | 0.01% | 688 |
|
|
2016
Q3 | – | Sell |
-97,146
| Closed | -$3.23M | – | 786 |
|
|
2016
Q2 | $3.23M | Buy |
97,146
+80,976
| +501% | +$2.77M | 0.06% | 180 |
|
|
2016
Q1 | $475K | Sell |
16,170
-16,098
| -50% | -$444K | 0.01% | 430 |
|
|
2015
Q4 | $849K | Buy |
+32,268
| New | +$838K | 0.02% | 264 |
|
Other funds holding EW
VCM
VPM
Capstone Investment Advisors's EW Position: Q1 2026 in Review
Capstone Investment Advisors reduced its Edwards Lifesciences (EW) stake by 45% in Q1 2026, selling an estimated $272K and leaving 4,024 shares worth $322K. The position accounts for ﹤0.01% of the portfolio, ranked #1343.
Capstone Investment Advisors first reported a position in EW in Q4 2015 and has held it in 31 quarters since. The position peaked at $4.19M in Q3 2022. 1,287 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Capstone Investment Advisors held 4,024 shares of Edwards Lifesciences worth $322K as of Q1 2026.
- Capstone Investment Advisors sold 3,294 Edwards Lifesciences shares in Q1 2026, an estimated $272K.
- Edwards Lifesciences made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1343 holding.
- Capstone Investment Advisors first reported a position in Edwards Lifesciences in Q4 2015 and has held it in 31 quarters since.
- Capstone Investment Advisors's Edwards Lifesciences position peaked at $4.19M in Q3 2022.
- 1,287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.